MANISHA NIDAMARTHY: Open Payments
NPI 1366176398 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 23 payments from 9 companies in 2025. Trend: 2023 $365 · 2024 $660 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $134 |
| Exact Sciences Corporation | 3 | $54 |
| Lilly USA, LLC | 3 | $49 |
| PFIZER INC. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| Verona Pharma, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: QULIPTA, XIFAXAN, RELISTOR, Cologuard Collection Kit, MOUNJARO, PREVNAR 20, VOQUEZNA, Ozempic.
Industry payments across NJ — which companies pay providers there.
